PPARG and type 2 diabetes mellitus: In T2D models, PPARγ activation prevents glomerular endothelial dysfunction and podocyte injury, inhibits NF-κB activation, reduces reactive oxygen species (ROS) accumulation, and limits macrophage infiltration in renal tissue.408